Successful Rechallenge of Clozapine Therapy Following Previous Clozapine-Induced Myocarditis Confirmed on Cardiac MRI

Bray A , Reid R : Successful clozapine rechallenge after acute myocarditis. Aust N Z J Psychiatry, 45:90, 2011.

Friedrich MG , Sechtem U , Schulz-Menger J , Holmvang G , Alakija P , Cooper LT , White JA , Abdel-Aty H , Gutberlet M , Prasad S , Aletras A , Laissy JP , Paterson I , Filipchuk NG , Kumar A , Pauschinger M , Liu P : Cardiovascular magnetic resonance in myocarditis: A JACC white paper. J Am Coll Cardiol, 53:1475–1487, 2009.

Haas SJ , Hill R , Krum H , Liew D , Tonkin A , Demos L , Stephan K , McNeil J : Clozapine-associated myocarditis: A review of 116 cases of suspected myocarditis associated with the use of clozapine in Australia during 1993–2003. Drug Saf, 30:47–57, 2007.

Hauck AJ , Kearney DL , Edwards WD : Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: Implications for role of sampling error. Mayo Clin Proc, 64:1235–1245, 1989.

Jayathilake I , Singh AK : Clozapine rechallenge after myocarditis. Australas Psychiatry, 17:421–422, 2009.

Kilian JG , Kerr K , Lawrence C , Celermajer DS : Myocarditis and cardiomyopathy associated with clozapine. Lancet, 354:1841–1845, 1999.

Lang RM , Bierig M , Devereux RB , Flachskampf FA , Foster E , Pellikka PA , Picard MH , Roman MJ , Seward J , Shanewise JS , Solomon SD , Spencer KT , Sutton MS , Stewart WJ . Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr, 18:1440–1463, 2005.

Manu P , Sarpal D , Muir O , Kane JM , Correll CU . When can patients with potentially life-threatening adverse effects be rechallenged with clozapine? A systematic review of the published literature. Schizophr Res, 134:180–186, 2012.

Meltzer HY , Alphs L , Green AI , Altamura AC , Anand R , Bertoldi A , Bourgeois M , Chouinard G , Z. Islam M , Kane J , Krishnan R , Lindenmayer JP , Potkin S , International Suicide Prevention Trial Study: Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).(Erratum appears in Arch Gen Psychiatry 60:735, 2003). Arch Gen Psychiatry, 60: 82–91, 2003.

Merrill DB , Dec GW , Goff DC : Adverse cardiac effects associated with clozapine. J Clin Psychopharmacol, 25:32–41, 2005.

Reid P : Clozapine rechallenge after myocarditis. Aust N Z J Psychiatry, 35:249, 2001.

Ronaldson KJ , Fitzgerald PB , Taylor AJ , McNeil JJ : Observations from 8 cases of clozapine rechallenge after development of myocarditis. J Clin Psychiatry, 73:252–254, 2012.

Rosenfeld AJ , Gibbs T , Ivie R , Clarke L , Merrill DB : Successful clozapine retrial after suspected myocarditis. Am J Psychiatry, 167:350–351, 2010.

Scelsa SN , Simpson DM , McQuistion HL , Fineman A , Ault K , Reichler B : Clozapine-induced myotoxicity in patients with chronic psychotic disorders. Neurology, 47:1518–1523, 1996.